OR Manager Conference (formerly Managing Today’s OR Suite), brings together more than 1, 400 managers and directors involved in leading the surgical suite for 3 days of continuing education and networking opportunities. The conference builds on the content developed in each issue of OR Manager, providing you with a live learning experience. Earn CEs, AEUs, and explore new technologies with solution providers.
OR Manager Conference provides you with plenty of opportunities to earn contact hours throughout the three days you will spend in New Orleans!Learn More
Editor’s Note This study found no evidence that value-based incentive programs (VBIPs), which link financial incentives or penalties to hospital performance, had any measurable association with changes in catheter-associated urinary tract infection (CAUTI) rates. Researchers at Boston University School of Medicine analyzed 592 hospitals across the country, and found that implementation of VBIPs was not […]
The post Government payment policies linked to hospital performance fail to improve CAUTI rates appeared first on OR Manager.
Editor’s Note The Joint Commission on February 13 announced the revision of its Sentinel Event Alert on diagnostic radiation, which was updated to also address risks associated with fluoroscopy. The original Alert, “Issue 47: Radiation risks of diagnostic imaging and fluoroscopy was published in August 2011.
The post Joint Commission revises Sentinel Event Alert on diagnostic radiation appeared first on OR Manager.
Editor’s Note Because a subset of patients are responsible for a disproportionate share of Medicare spending, targeting high-cost patients (ie, “hot spotting”) for cost containment efforts would be an effective strategy to reduce costs in surgical patients, this study finds. Using Medicare claims data from 2010 to 2013, University of Michigan, Ann Arbor, researchers found […]
The post Use of ‘hot spotting’ to identify high-cost surgery patients appeared first on OR Manager.
Editor’s Note The Food and Drug Administration (FDA) on February 5 identified the recall by Edwards Lifesciences (Irvine, California) of its Swan-Ganz Thermodilution Catheter as Class I, the most serious. The recall was initiated because of incorrect assembly and reversal of catheter lumens that can expose the patient to serious adverse health consequences or death. […]
The post FDA: Class I recall of Edwards Lifesciences Swan-Ganz Thermodilution Catheter appeared first on OR Manager.